CDKI-73 also induced dose- and time-dependent apoptosis in AML and ALL cell lines and patient derived primary cells, as demonstrated by enhanced PARP and Caspase-3 cleavages and reduced expressions of XIAP and MCL-1 protein and mRNA [153]. This evidence concerns the gene CASP3 and acute lymphoblastic leukemia.